Marcus Capital’s Pfizer PFE Stock Holding History

Marcus Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$274K	Sell	6,561 -527	-7%	-$20.3K	0.8%	37
2018 Q2	$244K	Hold	7,088	–	–	0.78%	39
2018 Q1	$239K	Sell	7,088 -158	-2%	-$5.43K	0.88%	36
2017 Q4	$249K	Hold	7,246	–	–	0.95%	36
2017 Q3	$245K	Hold	7,246	–	–	0.35%	45
2017 Q2	$231K	Buy	7,246 +211	+3%	+$6.65K	0.2%	50
2017 Q1	$228K	Buy	7,035 +52	+0.7%	+$1.64K	0.21%	49
2016 Q4	$215K	Buy	6,983 +132	+2%	+$4.03K	0.23%	49
2016 Q3	$220K	Buy	6,851 +105	+2%	+$3.51K	0.21%	51
2016 Q2	$225K	Sell	6,746 -421	-6%	-$13.4K	0.24%	50
2016 Q1	$202K	Hold	7,167	–	–	0.22%	51
2015 Q4	$220K	Buy	+7,167	New	+$225K	0.23%	47

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Marcus Capital's PFE Position: Q3 2018 in Review

Marcus Capital reduced its Pfizer (PFE) stake by 7.4% in Q3 2018, selling an estimated $20.3K and leaving 6,561 shares worth $274K. The position accounts for 0.8% of the portfolio, ranked #37.

Marcus Capital first reported a position in PFE in Q4 2015 and has held it in 12 quarters since. 2,256 funds tracked by Wall St. Rank hold PFE as of Q3 2018.

Marcus Capital held 6,561 shares of Pfizer worth $274K as of Q3 2018.
Marcus Capital sold 527 Pfizer shares in Q3 2018, an estimated $20.3K.
Pfizer made up 0.8% of Marcus Capital's portfolio in Q3 2018, its #37 holding.
Marcus Capital first reported a position in Pfizer in Q4 2015 and has held it in 12 quarters since.
2,256 funds tracked by Wall St. Rank held Pfizer as of Q3 2018.

Based on Marcus Capital's 13F filing for Q3 2018, filed 13 Nov 2018.